Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)
Israel · Delayed Price · Currency is ILS · Price in ILA 2,122.00
-10.00 (-0.47%)
Apr 24, 2026, 1:44 PM IDT
TLV:TKUN Revenue
In the year 2025, Tikun Olam-Cannbit Pharmaceuticals had annual revenue of 9.10M ILS, down -73.96%. Tikun Olam-Cannbit Pharmaceuticals had revenue of 14.10M in the half year ending December 31, 2024, a decrease of -49.90%.
Revenue
9.10M
Revenue Growth
-79.02%
P/S Ratio
1.98
Revenue / Employee
479.05K
Employees
19
Market Cap
18.03M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 9.10M | -25.85M | -73.96% |
| Dec 31, 2024 | 34.95M | -9.28M | -20.97% |
| Dec 31, 2023 | 44.23M | -5.07M | -10.28% |
| Dec 31, 2022 | 49.30M | 12.27M | 33.13% |
| Dec 31, 2021 | 37.03M | 15.37M | 70.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 55.02B |
| Danel (Adir Yeoshua) | 2.90B |
| Amal Holdings A.D. | 2.18B |
| BrainsWay | 166.49M |
| Erika Carmel-Tech | 37.34M |
| Bio-View | 19.93M |
| Evogene | 12.28M |
| XTL Biopharmaceuticals | 3.26M |